Cargando…

Biological Effects of Add-On Eicosapentaenoic Acid Supplementation in Diabetes Mellitus and Co-Morbid Depression: A Randomized Controlled Trial

BACKGROUND: Eicosapentaenoic acid (EPA) may reduce increased risks for (cardiovascular) morbidity and mortality in patients with diabetes mellitus (DM) and comorbid major depressive depression (MDD). Yet, effects of EPA-supplementation on biological risk factors for adverse outcomes have not been st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mocking, Roel J. T., Assies, Johanna, Bot, Mariska, Jansen, Eugene H. J. M., Schene, Aart H., Pouwer, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509102/ https://www.ncbi.nlm.nih.gov/pubmed/23209576 http://dx.doi.org/10.1371/journal.pone.0049431

Ejemplares similares

Plasma and Erythrocyte Fatty Acid Patterns in Patients with Recurrent Depression: A Matched Case-Control Study
por: Assies, Johanna, et al.
Publicado: (2010)

Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity
por: Assies, J, et al.
Publicado: (2014)

Ala54Thr Fatty Acid-Binding Protein 2 (FABP2) Polymorphism in Recurrent Depression: Associations with Fatty Acid Concentrations and Waist Circumference
por: Mocking, Roel J. T., et al.
Publicado: (2013)

Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder
por: Mocking, R J T, et al.
Publicado: (2016)

Statistical Methodological Issues in Handling of Fatty Acid Data: Percentage or Concentration, Imputation and Indices
por: Mocking, Roel J. T., et al.
Publicado: (2012)

Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence
por: Mocking, Roel J. T., et al.
Publicado: (2021)

Correction to: Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence
por: Mocking, Roel J. T., et al.
Publicado: (2021)

Aberrant default-mode network-hippocampus connectivity after sad memory-recall in remitted-depression
por: Figueroa, Caroline A, et al.
Publicado: (2017)

Fatty acids and recurrence of major depressive disorder: combined analysis of two Dutch clinical cohorts
por: Thesing, C. S., et al.
Publicado: (2019)

Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study
por: Mocking, Roel J T, et al.
Publicado: (2016)

Interaction between the MTHFR C677T polymorphism and traumatic childhood events predicts depression
por: Lok, A, et al.
Publicado: (2013)

Association of Coexisting Diabetes and Depression With Mortality After Myocardial Infarction
por: Bot, Mariska, et al.
Publicado: (2012)

The measurement of cognitive reactivity to sad mood in patients remitted from major depressive disorder
por: Figueroa, Caroline A., et al.
Publicado: (2018)

Disease management for co-morbid depression and anxiety in diabetes mellitus: design of a randomised controlled trial in primary care
por: Stoop, Corinne H, et al.
Publicado: (2011)

Depression recurrence is accompanied by longer periods in default mode and more frequent attentional and reward processing dynamic brain‐states during resting‐state activity
por: Alonso, Sonsoles, et al.
Publicado: (2023)

Impaired reward-related learning signals in remitted unmedicated patients with recurrent depression
por: Geugies, Hanneke, et al.
Publicado: (2019)

Diabetes MILES – The Netherlands: rationale, design and sample characteristics of a national survey examining the psychosocial aspects of living with diabetes in Dutch adults
por: Nefs, Giesje, et al.
Publicado: (2012)

Prevalence, associations and health outcomes of binge eating in adults with type 1 or type 2 diabetes: Results from Diabetes MILES – The Netherlands
por: Huisman, Sasja D., et al.
Publicado: (2022)

Altered ability to access a clinically relevant control network in patients remitted from major depressive disorder
por: Figueroa, Caroline A., et al.
Publicado: (2019)

Emotional Biases and Recurrence in Major Depressive Disorder. Results of 2.5 Years Follow-Up of Drug-Free Cohort Vulnerable for Recurrence
por: Ruhe, Henricus G., et al.
Publicado: (2019)

Neck dissection does not add to morbidity or mortality of laryngectomy
por: Xiao, Christopher C., et al.
Publicado: (2019)

Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia
por: Murphy, R A, et al.
Publicado: (2011)

Medication Intake, Perceived Barriers, and Their Correlates Among Adults With Type 1 and Type 2 Diabetes: Results From Diabetes MILES – The Netherlands
por: Hogervorst, Stijn, et al.
Publicado: (2021)

The Renoprotective Effects of Docosahexaenoic Acid as an Add-on Therapy in Patients Receiving Eicosapentaenoic Acid as Treatment for IgA Nephropathy: A Pilot Uncontrolled Trial
por: Moriyama, Takahito, et al.
Publicado: (2017)

Metabolomic profiles discriminating anxiety from depression
por: de Kluiver, Hilde, et al.
Publicado: (2021)

Dietary Supplementation With Eicosapentaenoic Acid Inhibits Plasma Cell Differentiation and Attenuates Lupus Autoimmunity
por: Kobayashi, Azusa, et al.
Publicado: (2021)

Re: ‘Cardiovascular outcomes of ethyl eicosapentaenoic acid in diabetes mellitus: a meta-analysis’
por: Philip, Sephy
Publicado: (2023)

RETRACTED: Cardiovascular outcomes of ethyl eicosapentaenoic acid in diabetes mellitus: A meta-analysis
por: Sattar, Yasar, et al.
Publicado: (2022)

Efficacy of eicosapentaenoic acid in inflammatory depression: study protocol for a match-mismatch trial
por: Suneson, Klara, et al.
Publicado: (2022)

Effect of Eicosapentaenoic Acid Supplementation on Paraoxonase 2 Gene Expression in Patients with Type 2 Diabetes Mellitus: a Randomized Double-blind Clinical Trial
por: Golzari, Mohammad Hassan, et al.
Publicado: (2019)

Eicosapentaenoic and docosahexaenoic acid supplementation and inflammatory gene expression in the duodenum of obese patients with type 2 diabetes
por: Labonté, Marie-Ève, et al.
Publicado: (2013)

Managing co-morbid depression and anxiety in primary care patients with asthma and/or chronic obstructive pulmonary disease: study protocol for a randomized controlled trial
por: Pommer, Antoinette M, et al.
Publicado: (2012)

Eicosapentaenoic Acid Supplementation Changes Fatty Acid Composition and Corrects Endothelial Dysfunction in Hyperlipidemic Patients
por: Yamakawa, Ken, et al.
Publicado: (2012)

Effect of vitamin D supplementation on health status in non-vitamin D deficient people with type 2 diabetes mellitus
por: Westra, S, et al.
Publicado: (2016)

Morbidity and doctor characteristics only partly explain the substantial healthcare expenditures of frequent attenders: a record linkage study between patient data and reimbursements data
por: Smits, Frans T, et al.
Publicado: (2013)

Effect of a cachectic factor on carbohydrate metabolism and attenuation by eicosapentaenoic acid
por: Hussey, H J, et al.
Publicado: (1999)

Helpful self-management strategies to cope with enduring depression from the patients’ point of view: a concept map study
por: van Grieken, Rosa A, et al.
Publicado: (2014)

Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women
por: Romo-Hualde, Ana, et al.
Publicado: (2018)

Depression and Risk of Mortality in People with Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: van Dooren, Fleur E. P., et al.
Publicado: (2013)

Effectiveness of adjuvant occupational therapy in employees with depression: design of a randomized controlled trial
por: Hees, Hiske L, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_r92huvul18e4qvqp9fmjptvm78